Home › T-Cell Lymphoma
Pag-aaral pangklinika para sa T-Cell Lymphoma na nagre-recruit sa U.S.
35 pag-aaral para sa T-Cell Lymphoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY12 pag-aaral
- Baldwin Park, CA10 pag-aaral
- Houston, TX9 pag-aaral
- Philadelphia, PA9 pag-aaral
- Atlanta, GA8 pag-aaral
- Boston, MA8 pag-aaral
- Chicago, IL6 pag-aaral
- Columbus, OH6 pag-aaral
- Rochester, MN6 pag-aaral
- Seattle, WA6 pag-aaral
- New Haven, CT5 pag-aaral
- Miami, FL5 pag-aaral
- Scottsdale, AZ4 pag-aaral
- Ann Arbor, MI4 pag-aaral
- Durham, NC4 pag-aaral
- Cedar Rapids, IA4 pag-aaral
- Baltimore, MD4 pag-aaral
- Charlottesville, VA4 pag-aaral
- Portland, OR4 pag-aaral
- St. Louis, MO4 pag-aaral
- Los Angeles, CA3 pag-aaral
- Aurora, CO3 pag-aaral
- Washington, DC3 pag-aaral
- Charlotte, NC3 pag-aaral
- Milwaukee, WI3 pag-aaral
- Rochester, NY3 pag-aaral
- Salt Lake City, UT3 pag-aaral
- Indianapolis, IN3 pag-aaral
- Tampa, FL3 pag-aaral
- Madison, WI3 pag-aaral
- Minneapolis, MN3 pag-aaral
- Denver, CO3 pag-aaral
- San Diego, CA3 pag-aaral
- San Francisco, CA3 pag-aaral
- Omaha, NE3 pag-aaral
- Cincinnati, OH3 pag-aaral
Ayos sa estado
- Arizona5 pag-aaral
- California14 pag-aaral
- Colorado6 pag-aaral
- Connecticut5 pag-aaral
- Florida8 pag-aaral
- Georgia9 pag-aaral
- Illinois7 pag-aaral
- Indiana3 pag-aaral
- Iowa4 pag-aaral
- Maryland5 pag-aaral
- Massachusetts8 pag-aaral
- Michigan5 pag-aaral
- Minnesota9 pag-aaral
- Missouri4 pag-aaral
- Nebraska3 pag-aaral
- New Jersey3 pag-aaral
- New York14 pag-aaral
- North Carolina6 pag-aaral
- Ohio8 pag-aaral
- Oklahoma3 pag-aaral
- Oregon4 pag-aaral
- Pennsylvania11 pag-aaral
- Texas10 pag-aaral
- Utah3 pag-aaral
- Virginia5 pag-aaral
- Washington6 pag-aaral
- Wisconsin5 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Azacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07388563Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07278856Tissue Repository: CTCL Collection Protocol
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT02840747Auto Stem Cell Transplant for Lymphoma Patients
Nagre-recruitPhase 2
Hanggang edad 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT03125642Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT04803201Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07691450Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Nagre-recruitObservasyonal na pag-aaral
Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06131801Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07356245Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07293403Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04234048Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06561048BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT04752826Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06724237A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06854653A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04104776Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT07382817CD45BE-HSPC + CART-45 Cells
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07451054Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
Nagre-recruitPhase 2
Edad 1 hanggang 18 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06390319Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07750886Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT03011814Allo HSCT Using RIC and PTCy for Hematological Diseases
Nagre-recruitPhase 2
Hanggang edad 75 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT05805605Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT03501576Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06508463CD4CAR for CD4+ Leukemia and Lymphoma
Nagre-recruitPhase 1
Edad 12 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT03829540A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 16, 2026 · NCT05463263Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.